In the present study, using liver-specific TRAF3-KO/-transgenic mice, we identified hepatocyte TRAF3 as a positive regulator of HFD-induced or genetically induced insulin resistance, inflammatory responses and hepatic steatosis. Here, TRAF3 is linked to fatty liver disease.